fda warning letters compounded semaglutide 2025 september Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of GLP-1 Drugs and Telehealth Providers FDA issued 25 warning letters

The Center for Disease Control (CDC) suggests 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity exercise weekly

Endothelial dysfunction: pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome

While chest pain is not a common side effect listed in FDA prescribing information, patients may experience chest discomfort through various mechanisms including gastrointestinal effects, reflux, or unrelated cardiac conditions

After co-cultured for 12 h at 37 C, the macrophages on the lower surface of inserts were fixed with 4% formaldehyde for 30 min, stained with DAPI, and counted according to the previously established protocol [40]